Catalyst
Slingshot members are tracking this event:
GW Pharma (GWPH) Expects to Present Phase 3 Data on Epidiolex at American Epilepsy Society Annual Meeting December 2-6
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
http://ir.gwpharm.com/releasedetail.cfm?ReleaseID=1002552
Related Projects
- Edison will be hosting a call to discuss the Epidiolex data and its potential in Epilepsy GWPH, ZGNX Executed On: Nov 15, 2016 at 01:15 PM EST
Related Keywords
Epidiolex, American Epilepsy Society, Annual Meeting, Dravet Syndrome, Lennox-gastaut Syndrome, Tuberous Sclerosis Complex, Infantile Spasms
